These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing next-generation offerings.

It’s a pool Lilly King knows very well, one she’s been racing at since she was 10-years-old. So, it’s only fitting that her last swim meet on U.S. soil would be right here, at the IU Natatorium. “This ...

National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said it would ...

Companies are always in the race for the top spot, and the only way to achieve it is by reaching a high market valuation. The ...

Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Village Health Workers in Zimbabwe use digital medical equipment and smartphones to diagnose and treat childhood ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ...

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

Eli Lilly's (LLY) sees a 60% sales jump from April to May in India for its obesity/ diabetes drug Mounjaro. Read more here.